Custom Synthesis
Product Description
ALL Chemistry Inc.
-
US
-
2022On CPHI since
-
25 - 49Employees
Company types
Categories
Specifications
ALL Chemistry Inc.
-
US
-
2022On CPHI since
-
25 - 49Employees
Company types
More Products from ALL Chemistry Inc. (2)
-
Product ADCs Technology Services
ADCs are one of the most promising new classes of drugs for treating cancers that are difficult to treat with traditional chemotherapy and believed to be the “next big thing” in the field of cancer therapy. ALL Chemistry Inc. offers our customers our state of the art Antibody-drug Conjugates technologies. ... -
Product Desloratadine
Desloratadine is a histamine H1-receptor antagonist that the FDA approved as a treatment for the relief of seasonal allergic rhinitis in patients 12 years or older.
ALL Chemistry Inc. resources (1)
-
News Antibody-drug Conjugates Technology
At ALL Chemistry Inc., we are proud to offer our customers our state of the art Antibody-drug Conjugates technologies. We understand that each customer's needs are different and that is why we are committed to providing a tailored solution for each and every one.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance